By Ivana Magovčević-Liebisch PhD, JD, CEO of VIGIL NEUROSCIENCE, as part of the From The Trenches feature of LifeSciVC
Compared to most industries, biotech life...
We just held our first-ever, and hopefully only, virtual Atlas Venture Annual Meeting for our investors.
Although science is winning in this pandemic, we’re clearly...
